- Wilson, David;
- Jiménez-Díaz, MB;
- Viera, S;
- Ibáñez, J;
- Mulet, T;
- Magán-Marchal, N;
- Garuti, H;
- Gómez, V;
- Cortés-Gil, L;
- Martínez, A;
- Ferrer, S
The emergence of resistance to available antimalarials requires the urgent development of new medicines. The recent disclosure of several thousand compounds active in vitro against the erythrocyte stage of Plasmodium falciparum has been a major breakthroug
